Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Resonance Health Ltd ( (AU:RHT) ) just unveiled an update.
Resonance Health Ltd has released updated shareholder information in compliance with ASX Listing Rule 4.10. This update includes details on corporate governance, securities distribution, and the top twenty security holders. The announcement replaces previous shareholder information from the company’s annual report and reflects the company’s commitment to transparency and regulatory compliance.
More about Resonance Health Ltd
Resonance Health is an Australian healthcare technology and services company that provides globally recognized quantitative assessments for managing human diseases. The company offers Software-as-Medical Devices (SaMDs) that have received regulatory clearances in the USA, Europe, UK, and Australia. Their products, which include FerriScan®, FerriSmart®, HepaFatScan®, HepaFatSmart®, LiverSmart®, and CardiacT2*, are used in clinical trials and endorsed by leading physicians worldwide.
Average Trading Volume: 358,270
Technical Sentiment Signal: Sell
Current Market Cap: A$18.36M
For detailed information about RHT stock, go to TipRanks’ Stock Analysis page.